• Flag United States US
  • Flag Australia AU
  • Flag Canada CA
  • Flag EUR EUR
  • Flag China CN
  • Flag Germany DE
  • Flag New Zealand NZ
  • Flag United Kingdom UK
  • Flag Ireland IE
  • Flag Mexico MX
  • Flag United Nations Global
  • All
mobile menu
business
COMPANY BENCHMARKING • UNITED STATES

Abbott Laboratories - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Abbott Laboratories stacks up to the competition and put relevant competitor and industry information at your fingertips.


Abbott Laboratories - Overview

Brands
EAS, Ensure, Similac, ZonePerfect
Description
Abbott Laboratories is a public company headquartered in Illinois with an estimated 115,000 employees. In the US, the company has a notable market share in at least eight industries: Medical Device Manufacturing, Drug & Alcohol Test Kit Manufacturing, Glucose Meter Manufacturing, Laboratory Information Management Systems, Meal Replacement Product Manufacturing, Infant Formula Manufacturing, Toxicology Laboratories, Medical Equipment Repair & Maintenance Services and Medical Equipment Repair & Maintenance Services. Their largest market share is in the Infant Formula Manufacturing industry, where they account for an estimated 58.6% of total industry revenue and are considered a Golden Goose because they display medium to strong market share and strong profit, but slower revenue growth than some of their peers.
Company Details

Registered Name: Abbott Laboratories

Company Type: Operating

Exchange: NYSE

Headquarters: 100 Abbott Park Rd, North Chicago, IL 60064

Website: http://www.abbott.com/

Employees: 115000

Abbott Laboratories - Operating Industries and Main Competitors

error_outline To view all of Abbott Laboratories's operating industries and competitors, see purchase options.

Abbott Laboratories - Products and Services

  • Infant Formula Manufacturing

    • Of the 3 core revenue-generating products and services in the Infant Formula Manufacturing industry, Abbott Laboratories offers:
    • Concentrated liquid formula
    • Powdered formula
    • Ready-to-feed formula

  • Toxicology Laboratories

    • Of the 6 core revenue-generating products and services in the Toxicology Laboratories industry, Abbott Laboratories offers:
    • Blood testing
    • Breath testing
    • Hair testing
    • Saliva testing
    • AAAAAAA - AAAAAAAA Market Share: x.x%

  • Medical Device Manufacturing

    • Of the 0 core revenue-generating products and services in the Medical Device Manufacturing industry, Abbott Laboratories offers:

    • Meal Replacement Product Manufacturing

      • Of the 3 core revenue-generating products and services in the Meal Replacement Product Manufacturing industry, Abbott Laboratories offers:
      • Edible bars and other
      • Powdered products
      • Ready-to-drink shakes
    error_outline To view Abbott Laboratories's full products and services, see purchase options.

    Abbott Laboratories - SWOT Analysis

    Strengths and weaknesses take into account internal factors, and are based on Abbott Laboratories's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Infant Formula Manufacturing, Toxicology Laboratories, Medical Device Manufacturing, Meal Replacement Product Manufacturing, Laboratory Information Management Systems, and Glucose Meter Manufacturing industries.
    Strengths
    Days Receivables: x.x%
    Purchase a membership to unlock the full SWOT analysis of this company.
    lock
    Rank: 2 of 3 peers
    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
    Annual Turnover: x.x%
    Purchase a membership to unlock the full SWOT analysis of this company.
    lock
    Rank: 2 of 3 peers
    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
    Weaknesses
    Credit Risk: x.x%
    Purchase a membership to unlock the full SWOT analysis of this company.
    lock
    Rank: 2 of 3 peers
    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
    Revenue per Employee: $xx
    Purchase a membership to unlock the full SWOT analysis of this company.
    lock
    Rank: 2 of 3 peers
    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
    Opportunities
    • AAAAA
    • AAAAA
    • AAAAA
    Threats
    • AAAAA
    • AAAAA
    • AAAAA

    error_outline To view Abbott Laboratories's full SWOT analysis, see purchase options.

    Abbott Laboratories - Financial Statements & Ratios

    pie_chartAbbott Laboratories Income Statement

    BALANCE DATE12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
    Revenue30,578.031,904.034,608.043,075.043,653.040,109.0
    Cost of Revenue000000000000000000000000
    Cost of Revenue, Non-Cash000000000000000000000000
    Gross Profit000000000000000000000000
    Other000000000000000000000000

    pie_chartAbbott Laboratories Balance Sheet

    BALANCE DATE12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
    Cash and Equivalents3,844.03,860.06,838.09,799.09,882.06,896.0
    Short-Term Investments000000000000000000000000
    Derivative Assets, Current000000000000000000000000
    Restricted Cash and Investments000000000000000000000000
    Other000000000000000000000000

    pie_chartAbbott Laboratories Cash Flow

    BALANCE DATE12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
    Net Income2,368.03,687.04,495.07,071.0N/AN/A
    Income (Loss) From Discontinued Operations000000000000000000000000
    Depreciation, Depletion and Amortization000000000000000000000000
    Amortization of Financing Costs and Discounts000000000000000000000000
    Other000000000000000000000000

    error_outline To view all financial data for Abbott Laboratories, see purchase options.

    GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

    100% Money Back Guarantee Digicert Trusted

    BENCHMARKING PRO

    What's Inside
    Benchmarking Pro?

    A suite of company and industry data that:

    Benchmarks companies against industry averages or like-sized segments, as well as close competitors
    Identifies real-world strengths, opportunites, weaknesses and threats
    Reveals growth opportunities or red flags in a business growth strategy
    LEARN MORE

    Included in Report

    • Enterprise History & Synopsis
      Enterprise History & Synopsis
    • Enterprise Financial Statements
      Company Financial Statements
    • Financial Ratios
      Industry Market Share Breakdown
    • Industry Averages
      Industry Competitor Matrix
    • Competitive Landscape
      SWOT Analysis
    • Key Enterprise Personnel
      Products and Services
    • Subsidiaries & Ownership Structure
      Key Company Benchmarks

    Why purchase access to Benchmarking Pro?

    This profile on Abbott Laboratories includes:

    • Company Overview
    • Company Revenue and Employee Data
    • Company Financial Statements
    • Industry Market Share Breakdown
    • Industry Competitor Matrix
    • SWOT Analysis
    • Products and Services
    • Key Company Benchmarks
    • Interconnected Competitor Profiles and Industry Reports
    • Full Access to Benchmarking Pro

    The IBISWorld Benchmarking Pro solution enables you to:

    • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
    • Benchmark companies against industry averages, segment averages and their competitors.
    • Identify real-world strengths, opportunities, weaknesses and threats for companies.
    • Target growth opportunities or spot red flags in a business growth strategy.
    • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

    IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Trusted by More Than 10,000 Clients Around the World

    • IBISWorld client - VISA
    • IBISWorld client - ADP
    • IBISWorld client - Deloitte
    • IBISWorld client - AMEX
    • IBISWorld client - Bank of Montreal